Cart
sales@molnova.com
Sancycline
CAS No. 808-26-4
Sancycline( Bonomycin | 6-Demethyl-6-deoxytetracycline )
Catalog No. M16022 CAS No. 808-26-4
A semi-synthetic tetracycline prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of Declomycin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 198 | In Stock |
|
| 100MG | 299 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 714 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSancycline
-
NoteResearch use only, not for human use.
-
Brief DescriptionA semi-synthetic tetracycline prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of Declomycin.
-
DescriptionA semi-synthetic tetracycline prepared by hydrogenolysis of the chloro and benzylic hydroxy moieties of Declomycin.
-
In Vitro——
-
In Vivo——
-
SynonymsBonomycin | 6-Demethyl-6-deoxytetracycline
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number808-26-4
-
Formula Weight414.4086
-
Molecular FormulaC21H22N2O7
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mg/mL
-
SMILESCN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C(=CC=C4)O)C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O
-
Chemical Name2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WCK-5153
WCK-5153 is an enhancer of β-Lactamase and an inhibitor of PBP2 with antimicrobial activities against Pseudomonas aeruginosa.
-
Flucloxacillin sodiu...
Flucloxacillin sodium is a highly active antibiotic against Gram-positive and Gram-negative bacteria.
-
Vancomycin
An antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.
